Cargando…

Lateral one-third gland resection in Cushing patients with failed adenoma identification leads to low remission rates: long-term observations from a small, single-center cohort

BACKGROUND: Currently, there are no guidelines for neurosurgeons treating patients with Cushing’s disease (CD) when intraoperative adenoma identification is negative. Under these circumstances, a total hypophysectomy or hemi-hypophysectomy on the side indicated by inferior petrosal sinus sampling (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andereggen, Lukas, Mariani, Luigi, Beck, Jürgen, Andres, Robert H., Gralla, Jan, Luedi, Markus M., Weis, Joachim, Christ, Emanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2021
Materias:	Original Article - Pituitaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520517/ https://www.ncbi.nlm.nih.gov/pubmed/33811521 http://dx.doi.org/10.1007/s00701-021-04830-2

Ejemplares similares

Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term
por: Andereggen, Lukas, et al.
Publicado: (2021)

SAT-279 Crooke’s Cell Adenoma- an Aggressive Form of Cushing’s Disease
por: Radovanovic, Natasa, et al.
Publicado: (2020)

SAT-300 Evading Death: Noxa in Cushing’s Disease Pituitary Adenomas
por: Alvarez, Reinier, et al.
Publicado: (2020)

Commentary: “Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery”
por: Andereggen, Lukas, et al.
Publicado: (2021)

SAT-304 Pituitary Stem Cells May Drive Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2020)

SAT-LB077 Remission and Mortality Rates in Patients with Cushing Disease According to Their Tumor Size
por: Lam-Chung, Cesar, et al.
Publicado: (2019)

SUN-450 Comorbidities in 419 Patients with Cushing's Disease in Remission: A Swedish Nationwide Study
por: Papakokkinou, Eleni, et al.
Publicado: (2019)

Management of Persistent Cushing’s Disease Despite Prior Pituitary Adenoma Resection in a Pregnant Patient
por: Leiter, Amanda, et al.
Publicado: (2021)

Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison With Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2021)

PMON93 Adenoma Size & Inferior Petrosal Sinus Sampling in Cushing's Disease Diagnosis - Smoke & Mirrors?
por: Hashmi, Hiba, et al.
Publicado: (2022)

Persistent bone impairment despite long-term control of hyperprolactinemia and hypogonadism in men and women with prolactinomas
por: Andereggen, Lukas, et al.
Publicado: (2021)

Sustained hypercortisolemia after bilateral adrenalectomy in Cushing's disease
por: Muradov, Ilkin, et al.
Publicado: (2023)

SAT-259 Acromegaly by Pituitary Adenoma Associated with ACTH-Independent Cushing Syndrome by Adrenal Carcinoma: Case Report
por: Minuzzi, Ricardo Kunde, et al.
Publicado: (2020)

Prolactinomas in adolescent and elderly patients—A comparative long-term analysis
por: Andereggen, Lukas, et al.
Publicado: (2023)

MON-295 Desmopressin Test in Silent Corticothoph Pituitary Adenomas, a Preliminary Study - a Comparison with Cushing Disease
por: Huayllas, Martha Katherine, et al.
Publicado: (2020)

OR01-02 Epigenomic Dysregulation Of PPP1R17 Drives The Cell Cycle In Adenomas Causing Cushing’s Disease
por: Asuzu, David, et al.
Publicado: (2023)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

THU012 Incidental Pituitary Adenoma In A Patient With Ectopic ACTH Secreting Cushing Syndrome - A Diagnostic Conundrum
por: Nali, Meenakshi Sinduri, et al.
Publicado: (2023)

MON-444 Defining Remission In Cushing Syndrome After Tumor Resection In Cases Of Non-suppressed Postoperative Serum Cortisol Levels
por: McGlotten, Raven, et al.
Publicado: (2019)

THU013 A Rare Case of Ectopic Cushing’s Syndrome Caused By Metastatic Parotid Gland Carcinoma
por: Punni, Emma, et al.
Publicado: (2023)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

MON-LB074 Ultrasonography May Reliably Assess Muscle Architecture in Patients with Cushing's Syndrome in Remission: Comparison with Gold-Standard Muscle MRI
por: Martel, Luciana, et al.
Publicado: (2019)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Machine Learning for Outcome Prediction in First-Line Surgery of Prolactinomas
por: Huber, Markus, et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

SAT-256 The Ever Confusing Cushing’s Work Up: Is It Real? Is It Pseudo Cushing’s’? Or Could It Be Factitious
por: Ghalib, Luma, et al.
Publicado: (2020)

THU044 The Subcellular Localization Of β-Catenin Is Associated With Tumor Size And The Surgical Remission Rate In Growth Hormone-producing Pituitary Adenomas
por: Kuwabara, Saki, et al.
Publicado: (2023)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Occult Carcinoid Causes Cushing’s Syndrome
por: Meftali, Sabrina, et al.
Publicado: (2021)

Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies
por: Varlamov, Elena V, et al.
Publicado: (2019)

THU021 Mysterious Resolution Of Cushing’s Disease
por: Whiteman, Daniel R, et al.
Publicado: (2023)

Somatotroph Adenomas have a Predilection to Invade the Cavernous Sinus and Resection of the Medial Wall of the Cavernous Sinus Offers the Highest Potential for Biochemical Remission in Acromegaly
por: Mohyeldin, Ahmed, et al.
Publicado: (2021)

GH-Producing pituitary adenoma and concomitant Rathke's cleft cyst: A case report
por: Yaman Kalender, Derya Sema, et al.
Publicado: (2023)

OR06-01 The Role of Germline Defects in Cushing’s Disease
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2020)

SAT-277 A Fierce Presentation of Cushing Disease
por: Al Sabie, Farah Laith, et al.
Publicado: (2020)

Antisense Oligonucleotides as a Novel Therapy for Cushing’s Disease
por: Eltumi, Hanan, et al.
Publicado: (2021)

SAT-LB46 Depression as an Atypical Presentation of Cushing’s Disease
por: Pahwa, Dhivya, et al.
Publicado: (2020)

MON-328 Disorders of Glucose Metabolism in Cushing Syndrome in Uzbekistan
por: Narimova, Gulchekhra Djumaniyazovna, et al.
Publicado: (2020)

USP8 Somatic Mutations in Cushing’s Disease and Silent Corticotropinomas
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hr3r5k941l37stfle5fe4abqri